Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...
It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?
Researchers create new compound to potentially treat negative and positive symptoms of schizophrenia
We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea, for example. These ...
3d
Miss Print on MSNAlone With You in the Ether by Olivie Blake: A ReviewWhen you learn a new word, you suddenly see it everywhere. The mind comforts itself by believing this to be coincidence but it isn’t–it’s ignorance falling away. Your future self will always see what ...
Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...
Before lithium became available to treat this potentially devastating illness, bipolar I sufferers experienced repeated ...
BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
The Food and Drug Administration has approved a new pain medication that could take the place of opioids for those experiencing moderate to severe acute pain. The drug is Journavx, or the generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results